MCPH1 maintains long-term epigenetic silencing ofANGPT2in chronic lymphocytic leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MCPH1 maintains long-term epigenetic silencing ofANGPT2in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
FEBS Journal
Volume 282, Issue 10, Pages 1939-1952
Publisher
Wiley
Online
2015-02-21
DOI
10.1111/febs.13245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiopoietins Promote Ovarian Cancer Progression by Establishing a Procancer Microenvironment
- (2014) Melissa K. Brunckhorst et al. AMERICAN JOURNAL OF PATHOLOGY
- Emerging roles of MCPH1: Expedition from primary microcephaly to cancer
- (2014) Thejaswini Venkatesh et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Deregulation of Microcephalin and ASPM Expression Are Correlated with Epithelial Ovarian Cancer Progression
- (2014) Rawiah Alsiary et al. PLoS One
- Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
- (2013) D. Gerald et al. CANCER RESEARCH
- Methylation of the hTERT Promoter: A Novel Cancer Biomarker for Leptomeningeal Metastasis Detection in Cerebrospinal Fluids
- (2013) S. Bougel et al. CLINICAL CANCER RESEARCH
- ANGPT2promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia
- (2013) Silvia Martinelli et al. Epigenetics
- MCPH1 protein expression and polymorphisms are associated with risk of breast cancer
- (2013) Yong Hwa Jo et al. GENE
- MCPH1/BRIT1 represses transcription of the human telomerase reverse transcriptase gene
- (2012) Lei Shi et al. GENE
- 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
- (2012) N Cahill et al. LEUKEMIA
- Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection
- (2012) Anders Rosén et al. OncoImmunology
- BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint
- (2011) C. Giallongo et al. ACTA HAEMATOLOGICA
- Identification and functional characterization of a primate-specific E2F1 binding motif regulating MCPH1 expression
- (2011) Lei Shi et al. FEBS Journal
- Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
- (2010) R. Maffei et al. BLOOD
- Regulation of Vascular Endothelial Growth Factor Receptors by Rb and E2F1: Role of Acetylation
- (2010) Smitha Pillai et al. CANCER RESEARCH
- Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features
- (2010) F. Vrbacky et al. Hematology
- BRIT1/MCPH1 Is Essential for Mitotic and Meiotic Recombination DNA Repair and Maintaining Genomic Stability in Mice
- (2010) Yulong Liang et al. PLoS Genetics
- Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
- (2009) Beverly L. Falcón et al. AMERICAN JOURNAL OF PATHOLOGY
- Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia
- (2009) M. Kanduri et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis
- (2008) Shan-Zhong Yang et al. EMBO REPORTS
- Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis
- (2007) Silvia Martinelli et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started